RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Clearwater, FL · Fleming Island, FL · Jacksonville, FL · +56 more sites
Obesity clinical trials in Orlando, FL
16 recruiting obesity studies with a site in Orlando, FL.
RecruitingPhase 2NCT07837973
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Sponsor: Alveus Therapeutics, Inc.
Bradenton, FL · Doral, FL · Orlando, FL · +17 more sites
RecruitingPhase 2NCT07589608
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Miami, FL · Miami Lakes, FL · New Port Richey, FL · +37 more sites
RecruitingPhase 2NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Sponsor: Eli Lilly and Company
Altamonte Springs, FL · Cutler Bay, FL · Maitland, FL · +27 more sites
RecruitingPhase 3NCT07794579
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Sponsor: Eli Lilly and Company
Boca Raton, FL · Miami, FL · +77 more sites
RecruitingPhase 2NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Fleming Island, FL · Miami, FL · Miami Lakes, FL · +47 more sites
RecruitingPhase 3NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Sponsor: Eli Lilly and Company
Orlando, FL · St. Petersburg, FL · +47 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
Miami, FL · Orlando, FL · +34 more sites
RecruitingPhase 3NCT06937099
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Sponsor: Eli Lilly and Company
Miami, FL · Orlando, FL · +32 more sites
RecruitingPhase 3NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Sponsor: Amgen
Jacksonville, FL · Lauderhill, FL · +68 more sites
RecruitingPhase 1NCT07793929
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Sponsor: Kailera
Orlando, FL · +1 more sites
RecruitingPhase 3NCT07533175
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Sponsor: Novo Nordisk A/S
Fleming Island, FL · Jacksonville, FL · Orlando, FL · +12 more sites
RecruitingPhase 3NCT07668414
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Sponsor: Novo Nordisk A/S
Hollywood, FL · Jacksonville, FL · +42 more sites
RecruitingPhase 3NCT07339423
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Sponsor: Novo Nordisk A/S
Miramar, FL · Orlando, FL · +20 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Altamonte Springs, FL · Aventura, FL · Boca Raton, FL · +118 more sites
RecruitingNot applicableNCT07464015
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Sponsor: University of Central Florida
Orlando, FL
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.